Literature DB >> 26338918

Autosomal Dominant Polycystic Kidney Disease and Intracranial Aneurysms: Is There an Increased Risk of Treatment?

M N Rozenfeld1, S A Ansari2, P Mohan3, A Shaibani2, E J Russell2, M C Hurley2.   

Abstract

BACKGROUND AND
PURPOSE: Autosomal dominant polycystic kidney disease is associated with an increased risk of intracranial aneurysms. Our purpose was to assess whether there is an increased risk during aneurysm coiling and clipping.
MATERIALS AND METHODS: Data were obtained from the National Inpatient Sample (2000-2011). All subjects had an unruptured aneurysm clipped or coiled and were divided into polycystic kidney (n = 189) and control (n = 3555) groups. Primary end points included in-hospital mortality, length of stay, and total hospital charges. Secondary end points included the International Classification of Diseases, Ninth Revision codes for iatrogenic hemorrhage or infarction; intracranial hemorrhage; embolic infarction; and carotid and vertebral artery dissections.
RESULTS: There was a significantly greater incidence of iatrogenic hemorrhage or infarction, embolic infarction, and carotid artery dissection in the patients with polycystic kidney disease compared with the control group after endovascular coiling. There was also a significantly greater incidence of iatrogenic hemorrhage or infarction in the polycystic kidney group after surgical clipping. However, the hospital stay was not longer in the polycystic kidney group, and the total hospital charges were not higher. Additional analysis within the polycystic kidney group revealed a significantly shorter length of stay but similar in-hospital costs when subjects underwent coiling versus clipping.
CONCLUSIONS: Patients with polycystic kidney disease face an increased risk during intracranial aneurysm treatment, whether by coiling or clipping. This risk, however, does not translate into longer hospital stays or increased hospital costs. Despite the additional catheterization-related risks of dissection and embolization, coiling results in shorter hospital stays and similar mortality compared with clipping.
© 2016 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2015        PMID: 26338918      PMCID: PMC7959947          DOI: 10.3174/ajnr.A4490

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  21 in total

1.  Better outcomes with treatment by coiling relative to clipping of unruptured intracranial aneurysms in the United States, 2001-2008.

Authors:  W Brinjikji; A A Rabinstein; D M Nasr; G Lanzino; D F Kallmes; H J Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-21       Impact factor: 3.825

2.  Spontaneous artery dissection: is it part of the spectrum of autosomal dominant polycystic kidney disease?

Authors:  G Bobrie; F Brunet-Bourgin; S Alamowitch; P Coville; P Kassiotis; A Kermarrec; D Chauveau
Journal:  Nephrol Dial Transplant       Date:  1998-08       Impact factor: 5.992

Review 3.  Endovascular treatment of intracranial unruptured aneurysms: a systematic review of the literature on safety with emphasis on subgroup analyses.

Authors:  Olivier N Naggara; Augustin Lecler; Catherine Oppenheim; Jean-Francois Meder; Jean Raymond
Journal:  Radiology       Date:  2012-06       Impact factor: 11.105

Review 4.  Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: how to diagnose and who to screen.

Authors:  A B Chapman; A M Johnson; P A Gabow
Journal:  Am J Kidney Dis       Date:  1993-10       Impact factor: 8.860

5.  Autopsy study of unruptured incidental intracranial aneurysms.

Authors:  T Inagawa; A Hirano
Journal:  Surg Neurol       Date:  1990-12

Review 6.  Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review.

Authors:  J W Hop; G J Rinkel; A Algra; J van Gijn
Journal:  Stroke       Date:  1997-03       Impact factor: 7.914

7.  Spontaneous coronary artery dissection in a woman with polycystic kidney disease.

Authors:  Charles T Itty; Ahmad Farshid; Girish Talaulikar
Journal:  Am J Kidney Dis       Date:  2008-11-06       Impact factor: 8.860

8.  Risk factors for the development and rupture of intracranial berry aneurysms.

Authors:  S M de la Monte; G W Moore; M A Monk; G M Hutchins
Journal:  Am J Med       Date:  1985-06       Impact factor: 4.965

9.  Intracranial aneurysms in autosomal dominant polycystic kidney disease.

Authors:  A B Chapman; D Rubinstein; R Hughes; J C Stears; M P Earnest; A M Johnson; P A Gabow; W D Kaehny
Journal:  N Engl J Med       Date:  1992-09-24       Impact factor: 91.245

10.  Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography.

Authors:  P M Ruggieri; N Poulos; T J Masaryk; J S Ross; N A Obuchowski; I A Awad; W E Braun; J Nally; J S Lewin; M T Modic
Journal:  Radiology       Date:  1994-04       Impact factor: 11.105

View more
  11 in total

1.  Treatment of Unruptured Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: Primum Non Nocere.

Authors:  M Niemczyk
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-15       Impact factor: 3.825

2.  Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Irina M Sanchis; Shehbaz Shukoor; Maria V Irazabal; Charles D Madsen; Fouad T Chebib; Marie C Hogan; Ziad El-Zoghby; Peter C Harris; John Huston; Robert D Brown; Vicente E Torres
Journal:  Clin J Am Soc Nephrol       Date:  2019-07-30       Impact factor: 8.237

3.  Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Adrien Flahault; Dominique Joly
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-19       Impact factor: 8.237

4.  Cerebral Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Comparison of Management Approaches.

Authors:  D Andrew Wilkinson; Michael Heung; Amrit Deol; Neeraj Chaudhary; Joseph J Gemmete; B Gregory Thompson; Aditya S Pandey
Journal:  Neurosurgery       Date:  2019-06-01       Impact factor: 4.654

5.  Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD.

Authors:  Ao Li; Yuchen Xu; Song Fan; Jialin Meng; Xufeng Shen; Qian Xiao; Yuan Li; Li Zhang; Xiansheng Zhang; Guanqing Wu; Chaozhao Liang; Dianqing Wu
Journal:  JCI Insight       Date:  2018-03-08

Review 6.  Polycystic kidney disease.

Authors:  Carsten Bergmann; Lisa M Guay-Woodford; Peter C Harris; Shigeo Horie; Dorien J M Peters; Vicente E Torres
Journal:  Nat Rev Dis Primers       Date:  2018-12-06       Impact factor: 52.329

Review 7.  ADPKD: clinical issues before and after renal transplantation.

Authors:  Piergiorgio Messa; Carlo Maria Alfieri; Emanuele Montanari; Mariano Ferraresso; Roberta Cerutti
Journal:  J Nephrol       Date:  2016-10-20       Impact factor: 3.902

8.  Prevalence of Intracranial Aneurysms in Patients with Aortic Aneurysms.

Authors:  A Rouchaud; M D Brandt; A M Rydberg; R Kadirvel; K Flemming; D F Kallmes; W Brinjikji
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-02       Impact factor: 3.825

9.  Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.

Authors:  Ao Li; Song Fan; Yuchen Xu; Jialin Meng; Xufeng Shen; Jun Mao; Li Zhang; Xiansheng Zhang; Gilbert Moeckel; Dianqing Wu; Guanqing Wu; Chaozhao Liang
Journal:  J Cell Mol Med       Date:  2017-02-28       Impact factor: 5.310

10.  Should we screen for intracranial aneurysms in children with autosomal dominant polycystic kidney disease?

Authors:  Emma Y X Walker; Matko Marlais
Journal:  Pediatr Nephrol       Date:  2022-02-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.